{"id":"W2595403257","doi":"10.1007/s00280-017-3260-6","title":"A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech","keywords":"Chills; Medicine; Carboplatin; Internal medicine; Melanoma; Nausea; Oncology; Adverse effect; Paclitaxel; Phases of clinical research; Chemotherapy; Immunotherapy; Gastroenterology; myalgia; Cancer; Immunology; Cisplatin; Cancer research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001079891,0.001525796,0.002166248,0.0006125774,0.0004209372,0.001059405,0.001096485,0.001284812,0.003904974],"category_scores_gemma":[0.0005697349,0.000691077,0.001602857,0.0005411137,0.001000556,0.001002854,0.0003492839,0.003906563,0.0008845533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009543456,"about_ca_system_score_gemma":0.001584394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002034046,"about_ca_topic_score_gemma":0.004029053,"domain_scores_codex":[0.999582,0.0001760122,0.00001504903,0.00008328006,0.00003304936,0.0001107483],"domain_scores_gemma":[0.9995514,0.000074932,0.0000711674,0.00005189462,0.00002268706,0.0002280488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6230727,0.1276391,0.004170198,0.001123463,0.002209552,0.0003670868,0.0004585453,0.004782658,0.09533265,0.0006490318,0.004478507,0.1357166],"study_design_scores_gemma":[0.3915783,0.5885758,0.006587732,0.000028672,0.0005894927,0.0002537515,0.00008345155,0.001219164,0.00737275,0.0001614007,0.003516472,0.0000331011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917926,0.001978576,0.0009185813,0.0005187038,0.0001687482,0.001902851,0.0008094982,0.0001422183,0.001768232],"genre_scores_gemma":[0.9876298,0.002581742,0.001701815,0.0006086359,0.0001887083,0.001862891,0.00164354,0.00005939772,0.003723426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003904974,"threshold_uncertainty_score":0.01306343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01482268013146391,"score_gpt":0.3479693058060301,"score_spread":0.3331466256745662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}